HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Irene Lorand-Metze Selected Research

Refractory Anemia with Excess of Blasts (RAEM)

1/2017Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia.
6/2007Reduced expression of FLIP SHORT in bone marrow of low risk myelodysplastic syndrome.
1/2006Maturation-associated immunophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic syndromes.
2/2004Flow cytometric analysis of the expression of Fas/Fasl in bone marrow CD34+ cells in myelodysplastic syndromes: relation to disease progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Irene Lorand-Metze Research Topics

Disease

13Neoplasms (Cancer)
02/2022 - 11/2007
9Multiple Myeloma
10/2020 - 11/2007
8BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2019 - 01/2011
4Refractory Anemia with Excess of Blasts (RAEM)
01/2017 - 02/2004
4Sepsis (Septicemia)
08/2013 - 05/2010
3Acute Promyelocytic Leukemia
10/2021 - 01/2010
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
03/2016 - 03/2003
3Leukemia
02/2014 - 01/2011
3Febrile Neutropenia
08/2013 - 05/2010
3Septic Shock (Toxic Shock Syndrome)
08/2013 - 05/2010
3Hodgkin Disease (Hodgkin's Disease)
12/2010 - 06/2009
3Lymphoma (Lymphomas)
06/2008 - 03/2003
2Fever (Fevers)
08/2013 - 03/2011
2Disease Progression
10/2012 - 11/2007
2Neutropenia
10/2009 - 10/2006
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2008 - 01/2006
2Cytopenia
02/2004 - 03/2003
1Carcinoma (Carcinomatosis)
02/2022
1Lung Neoplasms (Lung Cancer)
02/2022
1Neoplasm Metastasis (Metastasis)
02/2022
1Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2021
1Anemia
10/2019
1Essential Thrombocythemia
07/2016
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2016
1Primary Myelofibrosis (Myelosclerosis)
10/2015
1Systemic Mastocytosis
10/2014
1Mastocytosis
10/2014
1Hematologic Neoplasms (Hematological Malignancy)
02/2014
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
06/2012
1Leukocytosis (Pleocytosis)
06/2012
1Hemorrhage
01/2012
1Scott Syndrome
01/2012
1Infections
02/2011
1HIV Infections (HIV Infection)
02/2011
1Hepatitis B
10/2006
1Iron Deficiencies
10/2006

Drug/Important Bio-Agent (IBA)

8Imatinib Mesylate (Gleevec)FDA Link
10/2019 - 01/2011
5ChromatinIBA
02/2022 - 01/2006
4Tyrosine Kinase InhibitorsIBA
01/2019 - 01/2013
3AntigensIBA
10/2021 - 01/2006
3Dasatinib (BMS 354825)FDA Link
01/2019 - 10/2014
3Messenger RNA (mRNA)IBA
03/2016 - 06/2007
3Proteins (Proteins, Gene)FDA Link
08/2013 - 03/2003
3Biomarkers (Surrogate Marker)IBA
08/2013 - 05/2010
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2013 - 03/2011
2Tyrosine (L-Tyrosine)FDA Link
01/2021 - 08/2013
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2020 - 11/2019
2nilotinibFDA Link
01/2019 - 08/2015
2Janus Kinase 2IBA
07/2016 - 01/2011
25-hydroxymethylcytosineIBA
03/2016 - 05/2015
25-Methylcytosine (5 Methylcytosine)IBA
03/2016 - 05/2015
2EnzymesIBA
03/2016 - 10/2006
2ruxolitinibIBA
02/2016 - 10/2015
2StathminIBA
10/2015 - 02/2014
2DNA (Deoxyribonucleic Acid)IBA
05/2015 - 01/2004
2AngiopoietinsIBA
08/2013 - 05/2010
2CytokinesIBA
02/2011 - 01/2005
2Glutathione Transferase (Glutathione S-Transferase)IBA
12/2010 - 06/2009
2Folic Acid (Vitamin M)FDA LinkGeneric
03/2008 - 10/2006
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
01/2021
1Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
10/2020
1Hemoglobins (Hemoglobin)IBA
10/2019
1CalreticulinIBA
05/2015
1midostaurinIBA
10/2014
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2014
1Angiopoietin-2IBA
08/2013
1Angiopoietin-1IBA
08/2013
1Thalidomide (Thalomid)FDA Link
10/2012
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2012
1HLA-DR Antigens (HLA-DR)IBA
06/2012
1Annexin A5IBA
01/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2012
1ThrombinFDA Link
01/2012
1VaccinesIBA
02/2011
1fms-Like Tyrosine Kinase 3IBA
01/2011
1NucleophosminIBA
01/2011
1AnthracyclinesIBA
12/2010
1Alkylating AgentsIBA
12/2010
1Serum AlbuminIBA
12/2010
1Mitoxantrone (Novantrone)FDA LinkGeneric
01/2010
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2010
1Benzene (Benzole)IBA
10/2009
1Glutathione S-Transferase piIBA
06/2009
1glutathione S-transferase T1IBA
06/2009
1Thymidylate SynthaseIBA
03/2008
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
03/2008
1Methionine (L-Methionine)FDA Link
03/2008
15-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA
03/2008
1methionine synthase reductaseIBA
03/2008
1Codon (Codons)IBA
11/2007
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
10/2006
1IronIBA
10/2006
1Rheumatoid FactorIBA
10/2006
1Pharmaceutical PreparationsIBA
10/2006

Therapy/Procedure

9Therapeutics
02/2022 - 04/2006
5Drug Therapy (Chemotherapy)
08/2013 - 06/2008
2Hematopoietic Stem Cell Transplantation
10/2012 - 12/2009
1AIDA protocol
01/2010
1Salvage Therapy
12/2009
1Blood Component Removal (Apheresis)
06/2008